Company intelligence / Profile preview

Mercury Pharma Group

London, England, United Kingdommercurypharms.com ↗

Ownership: Private
Employees: ~704
Development stage: Other

Overview

Mercury Pharma Group is an international specialty pharmaceutical company focused on the manufacture and sale of niche prescription pharmaceuticals and non-prescription medicines. It operates primarily in the UK and EU markets, with a global reach to over 50 countries. The company's product portfolio consists mainly of established, off-patent drugs that are already commercialized. Financially robust, it has demonstrated strong growth and profitability metrics in recent years.

Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

azapropazone

Discontinued

Partnerships

AmdipharmPartners Group

Beyond the preview

Go deeper on Mercury Pharma Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mercury Pharma Group.

Explore the full profile